• Torbjørn Furuseth, CEO and co-Founder of DoMore Diagnostics

  • 2023/10/12
  • 再生時間： 14 分
  • ポッドキャスト

Torbjørn Furuseth, CEO and co-Founder of DoMore Diagnostics

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Cancer therapies such as chemo and radiotherapy can be extremely aggressive but, for many patients and their clinicians, preserving quality of life is a major factor in choosing their treatment.

    Today, there are few in-depth diagnostic methods that can distinguish aggressive tumours - which require intense treatment - from mild tumours.

    DoMore Diagnostics is developing technology that analyses tumour tissue to help determine which patients will benefit from additional therapy.

    In this episode, we speak to CEO and co-Founder about his journey from consulting firm McKinsey to DoMore Diagnostics.
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Cancer therapies such as chemo and radiotherapy can be extremely aggressive but, for many patients and their clinicians, preserving quality of life is a major factor in choosing their treatment.

Today, there are few in-depth diagnostic methods that can distinguish aggressive tumours - which require intense treatment - from mild tumours.

DoMore Diagnostics is developing technology that analyses tumour tissue to help determine which patients will benefit from additional therapy.

In this episode, we speak to CEO and co-Founder about his journey from consulting firm McKinsey to DoMore Diagnostics.
続きを読む 一部表示

Torbjørn Furuseth, CEO and co-Founder of DoMore Diagnosticsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。